Moffitt Cancer Center is looking to recruit and treat 240 men and evaluate safety and effectiveness of Polyphenon E, a drug developed from green tea, in preventing the progression of early signs of prostate cancer. The goal is to also assess if Polyphenon E reduces urinary tract symptoms that men experience with this condition.

Full article: http://www.medicalnewstoday.com/articles/90124.php?nfid=20390